Thromboembolism.
Fitzmaurice
David A
DA
The Medical School University of Birmingham, Birmingham, United Kingdom.
Hobbs
F D Richard
FD
McManus
Richard J
RJ
D000925:Anticoagulants / Q000627:therapeutic use; D001458:Bandages; D003661:Decision Support Techniques; D004360:Drug Therapy, Computer-Assisted; D019317:Evidence-Based Medicine; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D015995:Prevalence; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D013923:Thromboembolism / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D014859:Warfarin; D006493:Heparin